Omnicef 1 g Injection Vial

Omnicef 1 G Injection Vial contains Ceftriaxone 1 g (as ceftriaxone sodium) powder for injection. Prescription required.

Treatment of susceptible bacterial infections such as pneumonia and other respiratory tract infections, urinary tract infections, typhoid fever, intra‑abdominal infections, skin/soft tissue infections, bone and joint infections, gonorrhoea, septicaemia, meningitis; perioperative surgical prophylaxis

Ceftriaxone is a third‑generation cephalosporin antibiotic. It kills bacteria by inhibiting bacterial cell wall synthesis through binding to penicillin‑binding proteins, leading to cell lysis.

For intravenous or intramuscular use only. Reconstitute the vial with the recommended diluent and administer as directed by a physician; dose and duration depend on infection type, severity, age and kidney/liver status. May be given with or without food (no relation for injections).

Injection site pain/swelling, diarrhoea, nausea, vomiting, abdominal pain, rash, itching, headache, dizziness, raised liver enzymes, eosinophilia

Prescription-only antibiotic; use only for bacterial infections. Do not use if allergic to ceftriaxone/cephalosporins; caution in severe penicillin allergy. Risk of C. difficile-associated diarrhoea; seek care for severe/persistent diarrhoea. Avoid/contraindicated in hyperbilirubinaemic neonates and in neonates receiving IV calcium-containing solutions (risk of precipitation). Use caution in liver disease, renal impairment (especially combined), history of colitis, gallbladder/biliary sludging. Long-term use may cause superinfection; monitor CBC and liver/renal function if prolonged therapy.

Calcium-containing IV solutions in neonates (contraindicated) and avoid mixing with calcium solutions in the same IV line; warfarin/other anticoagulants (increased bleeding risk—monitor INR); aminoglycosides/loop diuretics (increased nephrotoxicity risk—monitor); oral typhoid vaccine (reduced efficacy); probenecid (may increase cephalosporin levels)

Store unopened vial at or below 25°C, protected from light and moisture. After reconstitution, use as per label/clinical guidelines; do not freeze reconstituted solution unless specified by manufacturer.

Ceftriaxone 1 g Injection (various brands), Monocef 1 g Injection, Taxim 1 g Injection, Xone 1 g Injection, Ceftriax 1 g Injection